期刊文献+

CD10、Bcl-6、MUM1的表达与弥漫大B细胞淋巴瘤预后的关系 被引量:1

下载PDF
导出
摘要 弥漫大B细胞淋巴瘤(diffused large B cell lym-plaoma,DLBCL)是非霍奇金淋巴瘤(NHL)中最大的一个亚群,是成人最常见的NHL[1],约占NHL总数的30%~40%[2].在WHO关于淋巴系统肿瘤的分类[3]中,DLBCL被定义为:B细胞起源的,有大的肿瘤细胞,具有侵袭性临床表现,需要高效力化疗的一组恶性淋巴瘤,这类肿瘤发生于淋巴结内或结外,可原发或继发于其他低度恶性淋巴瘤的演进[4].
作者 韩泽 严智昌
出处 《肿瘤预防与治疗》 2010年第1期71-73,31,共4页 Journal of Cancer Control And Treatment
  • 相关文献

参考文献28

  • 1Rossi D,Galdano G.Molecular heterogeneity of diffuse large B-cell lymphoma:implications for disease management and prognosis[J].Hematology,2002,7(4):239-252.
  • 2Tomita N,Kodama F,Motomura S,et al.Prognostic faetors in diffuse large B-cell lymphoma treated by risk adopted thempy[J].Inter Med,2006,45(5):247.
  • 3Jaffe ES,Harris NL,Stein H,et al.World Health Organizationclassification of tumors.pathology and genetics of tumors of haematopoietic and lymphoid tissues[M].Lyon:IARC press,2001:111-235.
  • 4Sun X,Cordon LI,Peterson LC.Transformation of follicular lym-phoma to acute lymphoblastie leukemia[J].Arch Pathol Lab Med,2002,126:997-998.
  • 5Ohno T,Smir BN,Weisenburger DD,el al.Origin of the Hodgkin/Reed-Sternberg cell in chronic lymphocytic leukemia with "Hodgkin's transformation"[J].Blood,1998,91:1757-1761.
  • 6Konoen J,Bubendorf L,Kallionieni A,et al.Tissue microarrays for high throughput molecular profiling of tumor specimens[J].Nature Med,1998,4(7):844-847.
  • 7Amytage JO,Weisenburger DD.New approachto classifying non-Hodglcins lymphoma clinical features of the major histologic sub-types Non-Hodgkins Lymphoma Classification Projet[J].J Clin Oneol,1998,16:2780-2795.
  • 8Alizadeh AA,Eisen MB,Davis RE,et al.Distinct types of dif-fuse large B-cell lymphoma identified by gene expression profiling[J].Nature,2000,403:503-511.
  • 9Rosenwald A,Wrisht G,Chart WC,et al.The use of molecular profilingto predict survival after chemotherapy for diffuse large B-cell lymphoma[J].N Eng J Med,2002,346:1937-1947.
  • 10Colomo L,Lopez-GuillemoA,Pemles M,et al.Clinical impact of the differentiation profile assessed by immunophenotyping in pa-tients with diffuse large B-cell lymphoma[J].Blood,2003,101:78-84.

二级参考文献31

  • 1Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 2000,403:503-511.
  • 2Rosenwald A,Wright G,Chan WC,et al. The use of molecular profiling to prodict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med, 2002,346:1937-1947.
  • 3Tsuboi K, Iida S, Inagaki H,et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia, 2000 , 14:449-456.
  • 4Coiffier B. Diffuse large cell lymphoma. Curr Opin Oncol,2001 , 13:325-334.
  • 5Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004,103:275-282.
  • 6Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood, 2003,101:78-84.
  • 7Natkunam Y, Warnke RA, Montgomery K, et al. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol, 2001,14:686-694.
  • 8Ye BH,Rao RS,Chaganti K,et al.Cloning of BCL-6,the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma[J].Cancer Res,1993,53(12):2732-2735.
  • 9Dent AL,Vasanwala FH,Toney LM.Regulation of gene expression by the proto-oncogene BCL-6[J].Critical Reviews in Oncology/Hematology,2002,41(1):1-9.
  • 10Zhang A,Ohshima K,Sato K,et al.Prognostic clinicopathologic factors,including immunologic expression in diffuse large B-cell lymphomas[J].Pathol Int,1999,49(12):1043-1052.

共引文献24

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部